Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

Brennen WN. et al, (2024), Prostate

[123I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer.

Chan CY. et al, (2023), J Nucl Med, 64, 1965 - 1971

Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome.

O'Neill E. et al, (2023), Theranostics, 13, 1302 - 1310

Imaging PARP with [18F]rucaparib in pancreatic cancer models.

Chan CY. et al, (2022), Eur J Nucl Med Mol Imaging, 49, 3668 - 3678

Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy.

O'Neill E. and Cornelissen B., (2022), Nucl Med Biol, 108-109, 44 - 53

Combination Strategies to Improve Targeted Radionuclide Therapy.

Chan TG. et al, (2020), J Nucl Med, 61, 1544 - 1552

Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy.

O'Neill E. et al, (2020), J Nucl Med, 61, 743 - 750

89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma.

Poty S. et al, (2020), Theranostics, 10, 5802 - 5814

Imaging DNA Damage in vivo following [177Lu] Lu-DOTATATE therapy in a model of pancreatic neuroendocrine cancer

O'Neill E. et al, (2019), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46, S196 - S196

Drawing on biology to inspire molecular design: a redox-responsive MRI probe based on Gd(iii)-nicotinamide.

Harris M. et al, (2018), Chem Commun (Camb), 54, 12986 - 12989

Harnessing the properties of cobalt coordination complexes for biological application

Renfrew AK. et al, (2018), COORDINATION CHEMISTRY REVIEWS, 375, 221 - 233

Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.

O'Neill ES. et al, (2017), Inorg Chem, 56, 9860 - 9868

A cobalt(ii) complex with unique paraSHIFT responses to anions.

O'Neill ES. et al, (2017), Chem Commun (Camb), 53, 3571 - 3574

Reversible magnetogenic cobalt complexes

O'Neill ES. et al, (2016), RSC ADVANCES, 6, 30021 - 30027

Luminescent Lanthanoid Probes

O'Neill ES. and New EJ., (2014), LIGAND DESIGN IN MEDICINAL INORGANIC CHEMISTRY, 113 - 143

Include forthcoming?